Nanotechnology offers significant potential for the detection and evaluation of human reproductive hormone proteins associated with PCOS, such as LH, FSH, prolactin (PRL), and anti-Müllerian hormone (AMH). This evidence concerns the gene AMH and polycystic ovary syndrome.